IMMUNIC, INC.

IMUX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 92 employees
276
SEC Filings
$12.76
Close 2026-09-03
92
Employees

Business Summary

Immunic, Inc. is a late-stage biotechnology company developing oral therapies for neurologic and gastrointestinal diseases. Its lead candidate, vidofludimus calcium (IMU-838), is in Phase 3 trials for relapsing multiple sclerosis. IMU-856 targets gastrointestinal diseases including celiac disease and IBD via SIRT6 modulation. IMU-381 is a preclinical next-generation Nurr1 platform program. The company has no approved products and operates primarily from New York and Gräfelfing, Germany.

Latest Stock Quote

IMUX 2026-09-03 $12.76 O:$14.24 H:$14.92 L:$11.56 Vol:0.8M VWAP:$12.8086
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001280776-26-000005EDGAR81K words
2025-03-312024-12-310001280776-25-000005EDGAR68K words
2024-02-222023-12-310001280776-24-000004EDGAR67K words
2023-02-232022-12-310001280776-23-000004EDGAR76K words
2022-02-242021-12-310001280776-22-000006EDGAR—
2021-02-262020-12-310001280776-21-000009EDGAR—
2020-03-162019-12-310001280776-20-000009EDGAR—
2019-03-042018-12-310001280776-19-000025EDGAR—
2018-03-132017-12-310001280776-18-000013EDGAR—
2017-03-072016-12-310001280776-17-000010EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001280776-26-000018EDGAR31K words
2025-11-132025-09-300001280776-25-000017EDGAR29K words
2025-08-072025-06-300001280776-25-000012EDGAR28K words
2025-05-152025-03-310001280776-25-000008EDGAR22K words
2024-11-072024-09-300001280776-24-000018EDGAR23K words
2024-08-082024-06-300001280776-24-000014EDGAR22K words
2024-05-082024-03-310001280776-24-000009EDGAR20K words
2023-11-142023-09-300001280776-23-000018EDGAR24K words
2023-08-032023-06-300001280776-23-000013EDGAR22K words
2023-05-112023-03-310001280776-23-000010EDGAR21K words
2022-11-032022-09-300001280776-22-000021EDGAR—
2022-08-042022-06-300001280776-22-000017EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-110001193805-26-001219EDGAR1K words
2026-09-090001193805-26-001196EDGAR0K words
2026-08-110001193805-26-001071EDGAR4K words
2026-07-140001193805-26-000966EDGAR0K words
2026-04-010001193805-26-000382EDGAR1K words
2026-03-310001193805-26-000370EDGAR1K words
2026-02-260001193805-26-000181EDGAR3K words
2026-02-130001193805-26-000129EDGAR2K words
2026-01-060001193805-26-000011EDGAR1K words
2026-01-050001193805-26-000007EDGAR8K words

276 total filings indexed. 244 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

relapsing-multiple-sclerosis progressive-multiple-sclerosis celiac-disease inflammatory-bowel-disease graft-versus-host-disease brain-cancers autoimmune-diseases

Company Identity

CIK0001280776
TickerIMUX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersNew York City, New York
Websitehttps://www.imux.com
Listed2014-04-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 52b70e310b4cd746ecc74d61d92d2af9fbad7f481943af18c755f05e1999b877
parent: 88599bdc2dd1a8f52dd7b711d272d34f00d8e382c1ac54d1c5e234d60bb54c42
content hash: f5ff9934a8b5871ca654a56ba80df6c811ba394e2ebd6cd5a7724f693650e0a2
signed: 2026-09-29T12:01:51.057Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IMUX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IMUX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IMUX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.